文献速递妇产影像腹部MR

局部晚期宫颈癌同步放化疗中MRI直方图特征与治疗反应的关系

Association between MRI histogram features and treatment response in locally advanced cervical cancer treated by chemoradiotherapy.
PubMed 文献 · Eur Radiol · 2020-09-03

回顾性分析58例接受4周同步放化疗的局部晚期宫颈癌患者,于治疗前后行MRI并计算T2WI和ADC直方图特征。治疗后ADC50是唯一兼具良好观察者重复性且与治疗反应显著相关的特征,AUC为0.701,截断值1.357×10⁻⁶ mm²/s。

要点

  • 治疗后ADC50与治疗反应显著相关(p=0.036),AUC为0.701,截断值1.357×10⁻⁶ mm²/s。
  • 治疗前勾画和直方图特征观察者重复性良好(DSC>0.700;ICC>0.750),治疗后重复性降低。
  • 除T2WKurtosis外,所有直方图特征在治疗前后均发生显著变化。

核心结论

  • ADC和T2WI直方图特征可用于追踪局部晚期宫颈癌同步放化疗过程中的肿瘤变化。
  • 治疗后ADC50与治疗反应相关,且观察者重复性良好。

研究设计与样本

  • 回顾性分析58例接受4周同步放化疗方案的局部晚期宫颈癌患者,治疗前和治疗后均行MRI。
  • 由一名放射科医生在T2WI图像和ADC图上勾画感兴趣体积计算直方图特征。
  • 由两名放射科医生勾画的感兴趣体积用于评估两个时间点勾画和特征值的观察者重复性,采用Dice相似系数(DSC)和组内相关系数(ICC)。
  • 治疗反应定义为肿瘤体积缩小90%。

关键影像表现/征象

  • 治疗前勾画和特征重复性总体良好(DSC>0.700;ICC>0.750)。
  • 治疗后重复性低(DSC<0.700;ICC<0.750),但ADC均值和百分位数保持良好ICC评分。
  • 除T2WKurtosis外,所有特征在两次检查间均发生显著变化。

诊断标准与关键数值

  • 治疗后ADC50是唯一兼具良好观察者变异性和治疗反应组间显著差异的特征(p=0.036),AUC为0.701,截断值1.357×10⁻⁶ mm²/s。
  • 治疗反应定义为肿瘤体积缩小90%。
  • 治疗前重复性良好定义为DSC>0.700且ICC>0.750;治疗后重复性低定义为DSC<0.700且ICC<0.750。

临床应用与阅片要点

  • 治疗后ADC50可用于辅助评估局部晚期宫颈癌同步放化疗的治疗反应,阅片时需注意勾画重复性。
  • 治疗后勾画和多数特征重复性降低,但ADC均值和百分位数仍保持良好ICC评分。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVE: To examine the associations of histogram features of T2-weighted (T2W) images and apparent diffusion coefficient (ADC) with treatment response in locally advanced cervical cancer (LACC) following concurrent chemoradiotherapy (CCRT).

MATERIALS AND METHODS: Fifty-eight patients who underwent a 4-week CCRT regimen with MRI prior to treatment (pre-CCRT) and after treatment (post-CCRT) were retrospectively analysed. Histogram features were calculated from volumes of interest (VOIs) from one radiologist on T2W images and ADC maps. VOIs from two radiologists were used to assess observer repeatability in delineation and feature values at both time-points with the Dice similarity coefficient (DSC) and intraclass correlation coefficient (ICC). Treatment response was defined as a 90% reduction in tumour volume. Paired Mann-Whitney U tests were used to determine if features changed significantly between examinations. Two-sample Mann-Whitney U tests were used to identify features that were significantly different between response groups. Receiver operating characteristic (ROC) analysis was done on significantly different MRI features between treatment response groups.

RESULTS: Pre-CCRT delineation and feature repeatability were generally good (DSC > 0.700; ICC > 0.750). Post-CCRT repeatability was low (DSC < 0.700; ICC < 0.750), but ADC mean and percentiles retained good ICC scores. All features, except for T2WKurtosis, significantly changed between examinations. Post-CCRT ADC50 was the only feature that demonstrated both good observer variability and significant differences between treatment response groups (p = 0.036) and had an AUC of 0.701 with a cut-off of 1.357 × 10-6 mm2/s.

CONCLUSION: ADC and T2W histogram features could be used to track changes in LACC tumours undergoing CCRT. Post-CCRT ADC50 was associated with treatment response with good observer repeatability.

KEY POINTS: • Pre-treatment tumour delineation and histogram feature values had good observer repeatability, while these were less repeatable at post-treatment. • MRI histogram analysis could be used to track changes in the tumour as it undergoes concurrent chemoradiotherapy. • Post-treatment median ADC was associated with treatment response and had good repeatability.

来源:Eur Radiol,查看原文。版权归原作者所有。

引用

  1. Perucho JAU, Wang M, Tse KY, et al. Association between MRI histogram features and treatment response in locally advanced cervical cancer treated by chemoradiotherapy. Eur Radiol. 2020. PMID: 32885298. doi:10.1007/s00330-020-07217-6

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。